Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
PUT
Immunocore
IMCR
$1.73B
| $4.74M | ﹤0.01% |
+152,200
| New | +$5.54M |
|
2927
Klaviyo
KVYO
$4.73B
| $4.73M | ﹤0.01% |
133,784
-50,151
| -27% | -$1.45M |
|
|
MPT
2928
CALL
Medical Properties Trust
MPT
$2.81B
| $4.73M | ﹤0.01% |
808,800
+34,100
| +4% | +$168K |
|
2929
Vanguard ESG US Corporate Bond ETF
VCEB
$1.15B
| $4.73M | ﹤0.01% |
72,866
+49,846
| +217% | +$3.18M |
|
2930
Dick's Sporting Goods
DKS
$18.7B
| $4.72M | ﹤0.01% |
22,632
-224,989
| -91% | -$48.1M |
|
2931
PUT
Pultegroup
PHM
$25.3B
| $4.72M | ﹤0.01% |
32,900
-49,800
| -60% | -$6.33M |
|
2932
CALL
Watsco Inc
WSO
$13.6B
| $4.72M | ﹤0.01% |
9,600
+1,700
| +22% | +$817K |
|
2933
PUT
PACCAR
PCAR
$70.1B
| $4.72M | ﹤0.01% |
47,800
+3,900
| +9% | +$381K |
|
2934
Prestige Consumer Healthcare
PBH
$2.6B
| $4.71M | ﹤0.01% |
65,373
+14,434
| +28% | +$1.02M |
|
2935
Invesco International BuyBack Achievers ETF
IPKW
$557M
| $4.71M | ﹤0.01% |
110,029
-47,480
| -30% | -$1.96M |
|
2936
Global X Artificial Intelligence & Technology ETF
AIQ
$10.2B
| $4.7M | ﹤0.01% |
126,574
-3,438
| -3% | -$121K |
|
2937
AGF US Market Neutral Anti-Beta Fund
BTAL
$300M
| $4.7M | ﹤0.01% |
239,948
-300,980
| -56% | -$5.99M |
|
2938
CALL
RxSight
RXST
$260M
| $4.7M | ﹤0.01% |
95,100
+84,400
| +789% | +$4.32M |
|
|
EH
2939
CALL
EHang Holdings
EH
$435M
| $4.7M | ﹤0.01% |
332,300
+12,200
| +4% | +$160K |
|
2940
NEOS Nasdaq 100 High Income ETF
QQQI
$13.9B
| $4.7M | ﹤0.01% |
91,532
-20,885
| -19% | -$1.06M |
|
2941
PUT
Archer Daniels Midland
ADM
$36.9B
| $4.7M | ﹤0.01% |
78,600
-216,600
| -73% | -$13.2M |
|
2942
First Trust Capital Strength ETF
FTCS
$7.95B
| $4.69M | ﹤0.01% |
51,681
+7,896
| +18% | +$692K |
|
2943
Timken Company
TKR
$9.03B
| $4.69M | ﹤0.01% |
55,649
+14,873
| +36% | +$1.22M |
|
2944
PUT
Lamar Advertising Co
LAMR
$16.3B
| $4.69M | ﹤0.01% |
+35,100
| New | +$4.29M |
|
2945
CALL
Hamilton Insurance Group
HG
$3.56B
| $4.69M | ﹤0.01% |
+242,400
| New | +$4.33M |
|
2946
Casella Waste Systems
CWST
$5.69B
| $4.68M | ﹤0.01% |
47,083
-40,653
| -46% | -$4.21M |
|
2947
General Mills
GIS
$19.7B
| $4.68M | ﹤0.01% |
63,410
-149,531
| -70% | -$10.4M |
|
2948
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $4.68M | ﹤0.01% |
+70,940
| New | +$4.45M |
|
2949
Shutterstock
SSTK
$219M
| $4.68M | ﹤0.01% |
132,255
+64,434
| +95% | +$2.38M |
|
2950
BioMarin Pharmaceuticals
BMRN
$12.4B
| $4.68M | ﹤0.01% |
66,512
-142,780
| -68% | -$11.9M |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.